Robert Thomas
Internal Medicine · Coral Gables, FLNPI 1205899051
Payments from drug & device makers
Across 222 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Pharmaceuticals America, Inc.$620
- GSK$532
- AstraZeneca$475
- Lilly USA, LLC$418
- Amgen$398
- AbbVie$279
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,743100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 24 | $620 |
| GSK | 25 | $532 |
| AstraZeneca | 23 | $475 |
| Lilly USA, LLC | 20 | $418 |
| Amgen | 18 | $398 |
| AbbVie(2 entities) | 15 | $279 |
| Novartis | 12 | $270 |
| Pfizer | 8 | $198 |
| Idorsia Pharmaceuticals US Inc | 9 | $194 |
| Amarin Pharma, Inc. | 11 | $189 |
| Novo Nordisk | 7 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $157 |
| Abbott | 6 | $145 |
| Currax Pharmaceuticals LLC | 8 | $132 |
| Azurity Pharmaceuticals, Inc. | 5 | $121 |
| Eisai Inc. | 3 | $62 |
| Arbor Pharmaceuticals, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Redhill Biopharma Inc. | 3 | $49 |
| Merck | 2 | $35 |
| Edwards Lifesciences | 1 | $31 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $30 |
| Boehringer Ingelheim | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Medicure Pharma Inc. | 1 | $21 |
| Sanofi | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Saluda Medical Americas, Inc. | 1 | $14 |
How this compares
$4,743 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $29,319 |
| JardianceEmpagliflozin | 23 | $26,363 |
| EliquisApixaban | 22 | $23,383 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 17 | $21,301 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $19,167 |
| VascepaIcosapent Ethyl | 24 | $17,411 |
| EdarbiAzilsartan Medoxomil | 23 | $7,850 |
| GemtesaVibegron | 15 | $7,326 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,098 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 16 | $7,052 |
| LivaloPitavastatin Calcium | 12 | $6,379 |
| Nebivolol Hcl | 18 | $1,801 |
| Rosuvastatin Calcium | 141 | $1,677 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 14 | $1,578 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $1,531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr | $26 | $47,66440 claims |
| Novo NordiskOzempic | $161 | $29,31911 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $532 | $26,26551 claims |
| PfizerEliquis | $198 | $23,38322 claims |
| Arbor Pharmaceuticals, Inc.Edarbi, Edarbyclor | $59 | $14,90239 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $620 | $6,37912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Coral Gables
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Jeffrey RosenCoral Gables$17M
- Carlos IglesiasCoral Gables$6.6M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.